Now Available: Keloid Treatment Market Forecast and Growth 2016-2026

Keloid scars are heap-up scars that develop abruptly on the skin surface. Keloid scars are developed with injuries causing due to, acne, burns, ear piercing, chickenpox, surgical cuts, scratches and vaccination sites. According to the National Centre of Biotechnology, keloid scars are commonly seen in people between age group 10 to 20 years of age. Though keloid scars are benign, continuous growth of the scar may result in skin cancer. Due to high incidence of keloid scars, many companies are in currently in the process of developing block buster drug molecules that can cure keloid scares completely. Apart from biopharmaceutical and pharmaceutical companies, many universities and medical centers such as the Carmel Medical Center, the University of Schleswig-Holstein and the Northwestern University are also conducting clinical trials to develop drugs for keloid treatment.

Keloid Treatment Market: Drivers and Restraints

Increasing awareness about scare treatment products, technological advancement in keloid scare treatment, increasing appearance consciousness, growing expenditure on personal care, and changing lifestyle are endorsing the growth of keloid treatment market. However, the high cost of keloid treatment, side effects, complications during treatment, and pain during treatment are the factors that would hinder the growth of keloid treatment market.

Request free sample Report: http://www.futuremarketinsights.com/reports/sample/rep-gb-1313

Keloid Treatment Market: Segmentation

The global keloid treatment market is segmented based on type of product and treatment.

Based on product type, the global keloid treatment market is segmented into the following:

• Ointment

• Creams

• Elastic Wraps

• Sprays

• Oils

• Topical Gels/Gel sheets

Based on treatment options, the global keloid treatment market is segmented into the following:

• Surgical Treatment

• Laser treatment

• Radiation therapy

• Cry therapy

• Steroid injections

• Interferon...